MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

Search

Embecta Corp

Suletud

SektorTervishoid

13.88 2.66

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

13.36

Max

14.02

Põhinäitajad

By Trading Economics

Sissetulek

22M

46M

Müük

37M

296M

P/E

Sektori keskmine

9.401

36.442

Dividenditootlus

4.48

Kasumimarginaal

15.398

Töötajad

2,100

EBITDA

48M

111M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+18.26% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

4.48%

3.00%

Järgmine tulemuste avaldamine

25. nov 2025

Järgmine aktsia dividendi kuupäev (ex-date)

5. dets 2025

Turustatistika

By TradingEconomics

Turukapital

210M

782M

Eelmine avamishind

11.22

Eelmine sulgemishind

13.88

Uudiste sentiment

By Acuity

50%

50%

166 / 371 Pingereas Healthcare

Embecta Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. okt 2025, 23:25 UTC

Suurimad hinnamuutused turgudel

Salesforce Rises on New FY30 Financial Targets

15. okt 2025, 18:52 UTC

Tulu
Suurimad hinnamuutused turgudel

Prologis Shares Gain on Raised Outlook, Data Center Growth

15. okt 2025, 18:30 UTC

Omandamised, ülevõtmised, äriostud

Constellation Software to Buy U.K.'s Tecvia Holding

15. okt 2025, 17:19 UTC

Omandamised, ülevõtmised, äriostud

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

15. okt 2025, 17:11 UTC

Omandamised, ülevõtmised, äriostud

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

15. okt 2025, 23:48 UTC

Market Talk

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

15. okt 2025, 23:38 UTC

Market Talk

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15. okt 2025, 22:37 UTC

Market Talk

Economic Stars Are Aligning for RBA -- Market Talk

15. okt 2025, 21:44 UTC

Tulu

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

15. okt 2025, 20:50 UTC

Market Talk
Tulu

Financial Services Roundup: Market Talk

15. okt 2025, 20:44 UTC

Omandamised, ülevõtmised, äriostud

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

15. okt 2025, 20:44 UTC

Omandamised, ülevõtmised, äriostud

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

15. okt 2025, 20:43 UTC

Omandamised, ülevõtmised, äriostud

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

15. okt 2025, 20:34 UTC

Tulu

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

15. okt 2025, 20:31 UTC

Omandamised, ülevõtmised, äriostud

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

15. okt 2025, 20:17 UTC

Omandamised, ülevõtmised, äriostud

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

15. okt 2025, 19:06 UTC

Tulu

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

15. okt 2025, 19:04 UTC

Market Talk

Oil Futures Post Back-to-Back Losses -- Market Talk

15. okt 2025, 18:46 UTC

Market Talk

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

15. okt 2025, 18:23 UTC

Tulu

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

15. okt 2025, 17:37 UTC

Omandamised, ülevõtmised, äriostud

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

15. okt 2025, 17:34 UTC

Market Talk

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

15. okt 2025, 16:57 UTC

Tulu

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

15. okt 2025, 16:51 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica Doesn't Disclose Financial Details

15. okt 2025, 16:50 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

15. okt 2025, 16:49 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

15. okt 2025, 16:48 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

15. okt 2025, 16:48 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

15. okt 2025, 16:47 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica Buys Ikerian

15. okt 2025, 16:34 UTC

Market Talk

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Embecta Corp Prognoos

Hinnasiht

By TipRanks

18.26% tõus

12 kuu keskmine prognoos

Keskmine 16 USD  18.26%

Kõrge 25 USD

Madal 11 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Embecta Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

4 ratings

1

Osta

2

Hoia

1

Müü

Sentiment

By Acuity

166 / 371 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat